First‑in‑human Phase 1 study evaluates HER3‑targeted ATNM‑400 in metastatic castration‑resistant prostate cancer population, including patients with and without prior PSMA‑directed therapy ...

Siemens Healthineers and Nvidia aim to embed AI agents in the planning process for personalizing radiation therapies for ...

Actinium Pharmaceuticals ( ATNM) announced that its first-in-human Phase 1 study of ATNM-400, an investigational HER3-targeted radiotherapy, will be featured at the ESMO 2026 Congress in Madrid, Spain ...

Tampere University Hospital (Tays) has begun offering a new form of radiotherapy to treat rectal cancer in which a high dose of radiation is targeted at the tumor surface. The aim is to destroy the ...

We randomly assigned patients with T1-T2, N0-2 (≤ 4 cm) OPSCC to radiotherapy (RT) (with chemotherapy if N1-2) versus transoral robotic surgery plus neck dissection (TORS + ND) (with or without ...

A paired CT study of 17 left-sided breast cancer patients shows deep inspiration breath-hold significantly cuts radiation ...

A retrospective study of 391 women treated with radiotherapy for gynaecological cancers found herpetic reactivation in 5.6 ...

Radiotherapy, or radiation therapy, is the clinical use of high energy rays (ionizing radiation) to induce DNA damage in all exposed cells to ultimately kill cancer cells or prevent cancer growth.

IAEA is launching the Dosimetry Audit Network Database and Validation System (DAN DAVA) and a website to strengthen and ...

Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia's most experienced radiation oncology medical ...

Long-term outcomes of 18F-fluoromisonidazole positron emission tomography (FMISO PET)–guided major radiation dose de-escalation in HPV-associated oropharyngeal cancer: The 30 ROC approach. Impact of ...

Actinium Pharmaceuticals, Inc. announced that the first-in-human Phase 1 study of ATNM-400, a HER3-targeted, non-PSMA radiotherapy, in metastatic castration-resistant prostate cancer will be ...